• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Analytikerkommentar

Sell in May and go away? Not for Inderes

Inderes

Oversigt

  • Inderes' May revenue increased by 14% year-over-year to 1.9 MEUR, surpassing the 1.7 MEUR estimate by 12%, driven by recurring revenue and project timing.
  • The Finnish IPO market is recovering, with companies like Savox, KPY, and Reaktor planning listings, aligning with previous expectations.
  • Evli's exit from the research business strengthens Inderes' market position, as most of Evli's clients have transitioned to Inderes.
  • We maintain our long-term estimates and target price at 20 EUR, reiterating a buy recommendation, with Inderes' H1 results expected on 11.08.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Inderes' May revenue grew 14% YoY to 1,9 MEUR, exceeding our 1,7 MEUR estimate by 12%. According to management, growth was driven mainly by recurring revenue (research and software) with additional support from timings of project revenue.

May 2024∆%May 2025∆%May 2026∆%FY26 OldFY26 New
1,9 MEUR 15 %1,6 MEUR-12 %1,9 MEUR14 %20,7 MEUR20,8 MEUR

Recent momentum has been strong, and the competitive landscape is shifting in Inderes' favor.

The Finnish IPO pipeline is showing clear signs of recovery, which is consistent with our earlier expectations. For example: Savox, KPY and Reaktor have all announced listing intentions.

Evli's announced exit from the research business eliminates one credible domestic competitor, further consolidating Inderes' market position. It should be noted that almost all Evli’s research clients have already been commissioned by Inderes. In our view the exit happens in a good spot for Inderes, which will have easier time converting new listing to research clients in Finland.

We revise our Q2 revenue estimate to EUR 5,7 million and raise our full-year 2026 forecast to 20,8 (20,7) MEUR mainly driven by continued momentum in Inderes' domestic commissioned research business.

Million EurosQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026eQ3 2026eQ4 2026e
Revenue5,35,23,94,75,55,74,45,2
Other operating income0,00,00,10,00,00,00,00,0
Materials and services-1,1-1,0-0,6-0,8-1,1-1,1-0,6-0,9
Personnel expenses-2,9-2,9-1,9-2,8-3,0-3,0-2,0-2,9
Other operating
expenses
-0,8-1,2-0,7-0,8-0,8-0,8-0,7-0,7
         
EBITDA0,50,20,80,40,60,61,00,5
Depreciation and
amortization
-0,1-0,1-0,1-0,1-0,1-0,1-0,1-0,1
         
EBITA0,50,10,70,30,50,50,90,5
Amortization of
consolidated goodwill
-0,2-0,2-0,2-0,2-0,2-0,2-0,2-0,2
         
Operating profit (EBIT)0,30,00,50,10,30,30,80,3

We keep our long-term estimates and target price unchanged 20€. We also re-issue our buy recommendation.

Inderes will publish its H1 results on 11.08. We will release our preview of H1 a few weeks prior.

Inderes operates in the financial industry. The company provides a community platform for investors and listed companies. Via the platform, users can communicate with each other and exchange investment tips. The customers consist of both companies and private individuals. In addition, the company offers analysis services and a basis for investment decisions. The largest operations are in the Nordic region.

Læs mere på virksomhedsside

Forumopdateringer

Hej til forummet! Vi har udgivet en kort kommentar til omsætningen i maj. → Sell in May and go away? Not for Inderes Hilsen Student Coverage...
for 11 timer siden
17
SEB forventede 1,7 mio. EUR, og resultatet blev 1,9 mio. EUR. En del skyldes sandsynligvis timing, som Mikael påpeger i sin kommentar, men under...
i går
af Karhu Hylje
31
Inderes’ omsætning steg med 14 procent i maj 2026 | Kauppalehti
i går
af Nahka Tapsa
6
Nu er Auroora Yhtiöt også blevet føjet til listen over analyseklienter efter Posti og Framery. Produktet sælger fortsat godt, og nye børsnoterede...
8.6.2026, 06.41
af Karhu Hylje
32
Her følger en meddelelse vedrørende Inderes’ investor relations-events. Jeg afslutter mit ansættelsesforhold hos Inderes den 30. juni. Det betyder...
5.6.2026, 10.28
af eero_alas
100
Ud fra de offentlige overvågningslister kan man se, at vi allerede havde alle undtagen ét selskab som analysekunder fra Evlis dækning. Man skal...
2.6.2026, 12.25
af Mikael Rautanen
45
Endnu en omgang gode nyheder fra Inderes’ hjemmemarked, da Savox her til morgen annoncerede deres planer om en børsnotering. Inden for de seneste...
2.6.2026, 05.50
af Karhu Hylje
38